ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In spite of that, CML displays a peculiar BCR-ABL dependent gene signature conferring unique leukemogenic properties to the cells, including the aberrant readout of coordinated effects of transcription factors as well as aberrant epigenetic controls.